Foghorn Therapeutics Inc.

The current institutional shareholding score of Foghorn Therapeutics Inc. is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 72.78%, representing a quarter-over-quarter decrease of 2.53%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.69% of shares outstanding, with 0.32% decrease in holdings.